Skip to Content

MYLAN 1570 MYLAN 1570 (Terazosin Hydrochloride 10 mg)

Pill with imprint MYLAN 1570 MYLAN 1570 is Purple, Capsule-shape and has been identified as Terazosin Hydrochloride 10 mg. It is supplied by Mylan Pharmaceuticals Inc..

Terazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Terazosin 10 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN 1570 MYLAN 1570

Terazosin hydrochloride 10 mg MYLAN 1570 MYLAN 1570
Terazosin hydrochloride 10 mg MYLAN 1570 MYLAN 1570 Front
Terazosin hydrochloride 10 mg MYLAN 1570 MYLAN 1570 Back
Terazosin hydrochloride 10 mg MYLAN 1570 MYLAN 1570

Terazosin Hydrochloride

Imprint
MYLAN 1570 MYLAN 1570
Strength
10 mg
Color
Purple
Size
14.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Antiadrenergic agents, peripherally acting
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
Inactive Ingredients
lactose anhydrous, silicon dioxide, D&C Red No. 28, D&C Red No. 33, FD&C Blue No. 1, magnesium stearate, microcrystalline cellulose, corn starch, sodium lauryl sulfate, titanium dioxide, ferrosoferric oxide, D&C Yellow No. 10, FD&C Blue No. 2, FD&C Red No. 40, propylene glycol, shellac

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00378-1570 Mylan Pharmaceuticals Inc.
54569-4876 A-S Medication Solutions, LLC (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.